The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genocea Biosciences
Stock and Other Ownership Interests - Genocea Biosciences
Research Funding - Genocea Biosciences
Patents, Royalties, Other Intellectual Property - Genocea Biosciences

GEN-009, a neoantigen vaccine containing ATLAS selected neoantigens, to generate broad sustained immunity against immunogenic tumor mutations and avoid inhibitory peptides.
 
Roger B. Cohen
Consulting or Advisory Role - Alkermes; AstraZeneca; Cantargia AB; Genocea Biosciences; Heat Biologics; Innate Pharma; Kyn therapeutics; Takeda
Research Funding - Celldex (Inst); Genocea Biosciences (Inst); Heat Biologics (Inst); Innate Pharma (Inst); Kyn therapeutics (Inst); Merck (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Alkermes; Genocea Biosciences; Heat Biologics; Innate Pharma; Kyn therapeutics; Takeda
 
Przemyslaw Twardowski
Honoraria - Astellas Medivation; Bayer; Genentech/Roche; Janssen; Sanofi/Aventis
Consulting or Advisory Role - Janssen; Sanofi/Aventis
Speakers' Bureau - Astellas Pharma; Bayer; Genentech/Roche; Janssen; Sanofi
 
Melissa Lynne Johnson
Consulting or Advisory Role - Abbvie (Inst); Achilles Therapeutics (Inst); Association of Community Cancer Centers (ACCC) (Inst); Astellas Pharma (I); AstraZeneca (Inst); Atreca (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Gritstone Bio (Inst); Guardant Health (Inst); Incyte (Inst); Janssen Oncology (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Otsuka (I); Pfizer (Inst); Ribon Therapeutics (Inst); Sanofi (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Adaptimmune (Inst); Amgen (Inst); Apexigen (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Atreca (Inst); BeiGene (Inst); Birdie (Inst); Boehringer Ingelheim (Inst); Checkpoint Therapeutics (Inst); Corvus Pharmaceuticals (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dynavax Technologies (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Genmab (Inst); Genocea Biosciences (Inst); GlaxoSmithKline (Inst); Gritstone Bio (Inst); Guardant Health (Inst); Hengrui Pharmaceutical (Inst); Immunocore (Inst); Incyte (Inst); Janssen (Inst); Jounce Therapeutics (Inst); Kadmon (Inst); Lilly (Inst); Loxo (Inst); Lycera (Inst); Merck (Inst); Mirati Therapeutics (Inst); Neovia Oncology (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst); Regeneron (Inst); Ribon Therapeutics (Inst); Sanofi (Inst); Shattuck Labs (Inst); Stem CentRx (Inst); Syndax (Inst); Takeda (Inst); Tarveda Therapeutics (Inst); TCR2 Therapeutics (Inst); University of Michigan (Inst); WindMIL (Inst)
Travel, Accommodations, Expenses - Abbvie; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Daiichi Sankyo; EMD Serono; Exelixis; Genentech; Incyte; Janssen Oncology; Lilly; Merck; Novartis; Pfizer; Sanofi; Sysmex; Vapotherm
 
Maura L. Gillison
Consulting or Advisory Role - BioMimetix; Bristol-Myers Squibb; EMD Serono; Genocea Biosciences; Merck; Roche
Research Funding - Bristol-Myers Squibb (Inst); Genocea Biosciences (Inst)
 
Mark N. Stein
Consulting or Advisory Role - Exelixis; Exelixis; Merck Sharp & Dohme
Research Funding - Advaxis (Inst); Bristol-Myers Squibb (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst)
 
Ulka N. Vaishampayan
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EMD Serono; Exelixis; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Pfizer
 
Lisa McNeil
No Relationships to Disclose
 
Mara Shainheit
Employment - Genocea Biosciences
Stock and Other Ownership Interests - Genocea Biosciences
Research Funding - Genocea Biosciences
 
Daniel DeOliveira
Employment - Genocea Biosciences
Stock and Other Ownership Interests - Genocea Biosciences; Ipsen
 
Manish Jain
Employment - Genocea Biosciences
Stock and Other Ownership Interests - Genocea Biosciences
Travel, Accommodations, Expenses - Genocea Biosciences
 
Jessica Price
Stock and Other Ownership Interests - Genocea Biosciences
 
Richard Hernandez
Employment - Genocea Biosciences; Moderna Therapeutics (I)
Stock and Other Ownership Interests - Genocea Biosciences; Moderna Therapeutics (I)
Travel, Accommodations, Expenses - Genocea Biosciences; Moderna Therapeutics (I)
 
Arthur P. DeCillis
Employment - DeCillis Consulting
Leadership - DeCillis Consulting
Stock and Other Ownership Interests - Exelis
Consulting or Advisory Role - Arvinas; Codiak Biosciences; Cybrexa Therapeutics; CytomX Therapeutics; Daiichi Sankyo; Exelixis; Genocea Biosciences; Novartis; Pyramid Biosciences
Patents, Royalties, Other Intellectual Property - Exelixis
 
Narinderjeet Singh
Employment - Genocea Biosciences
Leadership - Genocea Biosciences
Stock and Other Ownership Interests - Genocea Biosciences
Research Funding - Genocea Biosciences
Patents, Royalties, Other Intellectual Property - Momenta Pharmaceuticals
Travel, Accommodations, Expenses - Genocea Biosciences
 
Jessica Flechtner
Employment - Genocea Biosciences
Leadership - Genocea Biosciences
Stock and Other Ownership Interests - Genocea Biosciences
Patents, Royalties, Other Intellectual Property - Genocea Biosciences
 
Thomas A. Davis
Employment - Genocea Biosciences
Leadership - Genocea Biosciences
Stock and Other Ownership Interests - Genocea Biosciences